Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2939 of 5804
-
Experimental combo targets Hard-to-Treat cancers
Disease control CompletedA phase Ib trial study of trabectedin when prescribed in combination with durvalumab in locally advanced/unresectable soft-tissue sarcoma and ovarian carcinomas.
Phase: PHASE1 • Sponsor: Institut Bergonié • Aim: Disease control
Last updated Jun 26, 2026 14:10 UTC
-
300-Patient study aims to unlock secrets of rare lung disease
Knowledge-focused Recruiting nowPrimary Ciliary Dyskinesias (PCD) are rare, autosomal recessive respiratory diseases, due to a defect in mucociliary clearance linked to abnormalities in the structure and/or function of the cilia. The variety of ciliary abnormalities identified reflects the genetic heterogeneity…
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
Immunotherapy after radiation shows promise in rare lung cancer
Disease control CompletedThis phase I trial studies the side effects and best way to give pembrolizumab after radiation therapy in treating patients with pleural malignant mesothelioma. Radiation therapy uses high energy radiation to kill tumor cells and shrink tumors. Immunotherapy with monoclonal antib…
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Could vitamin B2 and sunlight replace costly eye surgery?
Disease control TerminatedCorneal ectasia is characterized by irregularity and thinning of the cornea, causing the cornea to bulge forward and cause distorted vision and impaired visual acuity. Corneal ectasia is a complication after refractive (LASIK) surgery. It is also the primary problem in keratoconu…
Phase: NA • Sponsor: University of Missouri-Columbia • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Knee repair surgery may delay arthritis
Disease control ENROLLING_BY_INVITATIONThe results of this study will optimize the care for patients with a meniscus root tear. Surgeons will be able to determine if MRR (meniscus root repair) with transtibial pullout technique is an effective treatment and will identify potential risk factors for poor clinical outcom…
Phase: NA • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Could a short hormone course help men with low-risk prostate cancer avoid treatment?
Disease control CompletedMany prostate cancer are slow or non progressive forms that would never impair quality or quantity of like of life if undetected. For this localized prostate cancer, the recommendation is an active surveillance, however often experienced by the patient as a lack of care. Thus the…
Phase: PHASE2 • Sponsor: Institut Paoli-Calmettes • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Immune drug plus targeted chemo shows promise for liver cancer in early trial
Disease control OngoingThe purpose of the study is to find out the effects of using nivolumab with Drug Eluting Bead Transarterial Chemoembolization (deb-TACE) in the treatment of liver cancer.
Phase: EARLY_PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Heavy bleeding after birth linked to depression and anxiety risk
Knowledge-focused CompletedThe objective of this cross-sectional study is to assess the prevalence of depression at 2 months, 6 months, and 1 year postpartum in women who had an immediate postpartum hemorrhage (immediate PPH defined as blood loss ≥ 500 mL within 24 hours of delivery). The potential serious…
Phase: NA • Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated Jul 12, 2026 00:00 UTC
-
Breathing exercises show promise for asthma patients with breathing problems
Symptom relief CompletedDyspnoe can disable patients with asthma. Dysfunctional breathing (DB), resulting in dyspnoe, can mimic or exaggerate asthma. Around every forth patient with asthma have DB. Breathing exercises (BrEX) can improve asthma-related quality of live (QOL) in less severe asthma. No stud…
Phase: NA • Sponsor: Naestved Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
New light therapy aims to ease swallowing for esophageal cancer patients
Symptom relief OngoingThe purpose of this study is to establish the highest dose of laser light for WST-11 VTP to treat obstruction from esophageal cancer that can be safely given.
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
Magnetic pulses to the brain aim to quiet CRPS pain
Symptom relief Recruiting nowThe aim of the current study is to assess the efficacy of TMS in the treatment of Complex Regional Pain Syndrome (CRPS). It is hypothesized that participants who receive TMS (Group 1) relative to sham treatment (Group 2) once daily for two days will demonstrate a greater improvem…
Phase: NA • Sponsor: Stanford University • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Gene hunt: could your DNA predict clot danger after hip or knee surgery?
Knowledge-focused ENROLLING_BY_INVITATIONThis study seeks to uncover potential genetic determinants of pulmonary embolism (PE). Our translational goal is to ultimately identify certain genetic markers that will allow us to stratify patients in terms of their PE risk post total knee or total hip arthroplasty. The clinica…
Sponsor: University of Southern California • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Pelvic floor therapy may beat bladder treatments for chronic pain
Symptom relief OngoingWomen with interstitial cystitis/bladder pain syndrome (IC/BPS) have debilitating urinary frequency and urgency, and chronic pelvic or bladder pain perceived to be related to the bladder. Although many clinicians think that IC/BPS symptoms result from a bladder problem, tight pel…
Phase: PHASE2 • Sponsor: Corewell Health East • Aim: Symptom relief
Last updated Jul 11, 2026 00:00 UTC
-
Can pelvic floor exercises help pouch patients regain control?
Disease control CompletedMulti-centre, assessor-blinded, randomised controlled trial comparing physiotherapist-led behavioural intervention (including pelvic floor muscle training) to standard care, in the management of post-operative ileo-anal pouch patients.
Phase: NA • Sponsor: St Vincent's Hospital Melbourne • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New hope for tough blood cancers? early trial tests regorafenib
Disease control CompletedThis research study is studying a drug as a possible treatment for advanced myeloid malignancies including AML (acute myeloid leukemia), MDS (myelodysplastic syndrome) and MPN (myeloproliferative neoplasms) The intervention involved in this study is: -Regorafenib (Stivarga)
Phase: PHASE1 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Can yoga ease the burden of head and neck cancer treatment?
Symptom relief OngoingObjectives: Primary Aim: Examine the feasibility of a dyadic yoga program in 40 Head and Neck Cancer (HNC) patients undergoing radiotherapy (RT) and their family caregivers. Secondary Aims: 1\. Establish the initial efficacy of the yoga program in patients and their caregiver…
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
Immunotherapy combo studied for rare lung cancer, trial stopped early
Disease control TerminatedThis research study is studying a pair of immunotherapies as a possible treatment for malignant pleural mesothelioma. The drugs involved in this study are: * Durvalumab * Tremelimumab
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Water pill could boost liver cancer treatment
Disease control OngoingThe purpose of this study is to test the safety of Bumetanide , at different doses to find out what effects, if any, it has on people who undergo tumor TAE as part of their regular care. Bumetanide is a commonly used medication to reduce the amount of water in the body.
Phase: PHASE1, PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New hope for sickle cell pain: canakinumab shows promise in kids
Symptom relief CompletedThe study assesses the efficacy, safety and tolerability of ACZ885 (canakinumab) in pediatric and young adult patients with sickle cell anemia (SCA).
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Symptom relief
Last updated Jun 27, 2026 08:10 UTC
-
New study analyzes best donor match for AML stem cell transplants
Knowledge-focused Completed1. Study Objectives * To evaluate the effect of various clinical variables including HLA-disparity and NK cell-related variables, upon outcomes of allogeneic hematopoietic cell transplantation (HCT) using uniform conditioning regimen including busulfan, fludarabine, and antit…
Sponsor: Asan Medical Center • Aim: Knowledge-focused
Last updated Jun 26, 2026 13:52 UTC